167 related articles for article (PubMed ID: 32644119)
1. Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
Rich SN; Poschman K; Hu H; Mavian C; Cook RL; Salemi M; Spencer EC; Prosperi M
J Infect Dis; 2021 Mar; 223(5):866-875. PubMed ID: 32644119
[TBL] [Abstract][Full Text] [Related]
2. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis.
Jordan MR; Penazzato M; Cournil A; Vubil A; Jani I; Hunt G; Carmona S; Maphalala G; Mthethwa N; Watera C; Kaleebu P; Musanhu CC; Mtapuri-Zinyowera S; Dzangare J; Peeters M; Yang C; Parkin N; Bertagnolio S
Clin Infect Dis; 2017 Nov; 65(12):2018-2025. PubMed ID: 29020335
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.
Aghokeng AF; Vergne L; Mpoudi-Ngole E; Mbangue M; Deoudje N; Mokondji E; Nambei WS; Peyou-Ndi MM; Moka JJ; Delaporte E; Peeters M
Antivir Ther; 2009; 14(3):401-11. PubMed ID: 19474474
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
Mirzaei H; Eybpoosh S; Mehrabi F; Shojaei MR; Mirzazadeh A; Khezri M; Nasiri N; Sharifi H
BMC Infect Dis; 2024 Jan; 24(1):29. PubMed ID: 38166733
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
[TBL] [Abstract][Full Text] [Related]
8. Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
Bello G; Kagoli M; Chipeta S; Auld A; Chang JC; DeVos JR; Kim E; Mkungudza J; Payne D; Eliya M; Nyirenda R; Jahn A; Mzumara T; Mvula B; Dadabhai S; Namakhoma I; Babaye Y; Giron A; Jordan MR; Bertagnolio S; O'Malley G; Wadonda-Kabondo N
Antivir Ther; 2022 Aug; 27(4):13596535221121225. PubMed ID: 35976773
[TBL] [Abstract][Full Text] [Related]
9. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
[TBL] [Abstract][Full Text] [Related]
10. A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort.
Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Marrone G; Grossmann S; Neogi U; Tegbaru B; Sönnerborg A
BMC Infect Dis; 2019 Jul; 19(1):569. PubMed ID: 31262272
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.
Kiertiburanakul S; Chaiwarith R; Sirivichayakul S; Ditangco R; Jiamsakul A; Li PC; Kantipong P; Lee C; Ratanasuwan W; Kamarulzaman A; Sohn AH; Sungkanuparph S;
PLoS One; 2013; 8(6):e62057. PubMed ID: 23826076
[TBL] [Abstract][Full Text] [Related]
12. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
13. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Antiretroviral Resistance in Cuba, 2009-2014.
Alemán-Campos Y; Kourí-Cordellá V; Pérez-Santos L; Fonseca-Gómez C; Pérez-Ávila J; Ortega-González LM; Baños-Morales Y; Álvarez-López A; Correa-Sierra CB; Martínez-Montesinos Y; Soto-Brito Y; Limia-León CM; Campos-Díaz JR; Caturla-Fernández Y; Alvarez-Gainza D; Pintos-Saavedra Y; Añé-Kourí AL; Joanes-Fiol J
MEDICC Rev; 2018 Jul; 20(3):15-21. PubMed ID: 31242157
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
Nduva GM; Otieno F; Kimani J; Sein Y; Arimide DA; Mckinnon LR; Cholette F; Lawrence MK; Majiwa M; Masika M; Mutua G; Anzala O; Graham SM; Gelmon L; Price MA; Smith AD; Bailey RC; Medstrand P; Sanders EJ; Esbjörnsson J; Hassan AS
J Antimicrob Chemother; 2024 Feb; 79(2):287-296. PubMed ID: 38091580
[TBL] [Abstract][Full Text] [Related]
16. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.
Sen S; Tripathy SP; Chimanpure VM; Patil AA; Bagul RD; Paranjape RS
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):489-97. PubMed ID: 17506605
[TBL] [Abstract][Full Text] [Related]
18. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
Hu Z; Kuritzkes DR
J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
[TBL] [Abstract][Full Text] [Related]
19. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
